|
For Immediate Release
Contact: Lisa Finger, 919-933-2021,lfinger@biosignia.com
BioSignia Board Elects Chairman
July 26,
2011 -- BioSignia today announced the election of E. B. Chester as
Chairman of the Board of Directors of BioSignia. He was elected by
unanimous vote of the Directors at its recent quarterly meeting in
Raleigh, NC.
Mr. Chester joined the Board of Directors of
BioSignia in January of 2011 and has had an immediate impact on the
commercialization of BioSignia’s technologies. “I am proud to be the
Chairman of the Board of Directors of an organization that is poised
to become a market leader in several industries. It’s an honor,”
said Chester.
Mr. Chester’s business experience includes
ownership and executive management of privately and publically owned
businesses in Manufacturing, Cable Television, Outdoor Advertising,
Banking, Real Estate Aviation Services and Power sports. Currently
he and his family are one of the larger group owners of
Harley-Davidson dealerships in the United States.
“E. B.
Chester has been a valuable member of our Board of Directors,” said
John A. Williams, President and CEO of BioSignia. “His background in
finance and sales is a tremendous resource and BioSignia is
privileged to have someone with his experience leading our Board.”
Mr. Chester lives in Beaver Creek, Colorado and Paradise Valley,
Arizona. He will become an active member of BioSignia’s leadership.
For more information on BioSignia, please call 888.324.6627 or
email info@biosignia.com.
# # #
About BioSignia
Headquartered in Research Triangle Park, NC, BioSignia is a leading
technology company focused on bringing innovative assessment
solutions to the preventive health and life insurance markets. At
the core of BioSignia’s solutions is the company’s proprietary
synthesis modeling approach to morbidity and mortality assessment.
In 2004, Biosignia received the Disease Management Association of
America’s prestigious award for Best Enabling Tool for Disease
Management. Since then, the company’s talented R&D team has
continued to advance synthesis modeling, continuously updating it to
reflect the ever expanding need for effective disease and mortality
assessment. BioSignia’s technologies are currently being used by
hospital systems, health and wellness organizations, disease
management, clinical laboratories, and life insurance organizations.
In early 2010, BioSignia partnered with NBC’s The Biggest LoserŪ to
provide its advanced health assessment to contestants and viewers.
For more information, visit, www.biosignia.com.
|
